Mumbai-based Wockhardt has completed phase 3 clinical trials in nearly 400 patients. Pharma firm looking to file for regulatory approvals in India, US and other countries in 2025.
Results outlined in study published in journal ‘Nature’ this month. The results are from animal studies, says the paper, adding that the drug is now being tested in humans.
‘First Multicentric Point Prevalence Survey of Antibiotic Use at 20 NAC-NET Sites India 2021-22’ conducted by National Centre for Disease Control under Union health ministry.
Commonly-sold cold and flu medicine such as Cheston Cold, ear drops Candibiotic and painkiller Etogesic among list, pharma industry wants those who prescribe FDC to judge efficacy.
From 2000 to 2015, TB claimed 33 million lives and cost the world economy an estimated $616 billion. By 2030, a further $1 trillion and 28 million lives may be lost.
SEBI probe concluded that purported loans and fund transfers were paid back in full and did not amount to deceptive market practices or unreported related party transactions.
Many really smart people now share the position that playing cricket with Pakistan is politically, strategically and morally wrong. It is just a poor appreciation of competitive sport.
COMMENTS